Literature DB >> 11061667

Pharmacokinetics of indinavir and low-dose ritonavir in children with HIV-1 infection.

A M van Rossum, R de Groot, N G Hartwig, C M Weemaes, S Head, D M Burger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11061667     DOI： 10.1097/00002030-200009290-00022

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected children.

Authors:  A S Bergshoeff; P L A Fraaij; A M C van Rossum; G Verweel; L H Wynne; G A Winchell; R Y Leavitt; B-Y T Nguyen; R de Groot; D M Burger
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 2.  Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.

Authors:  Michael N Neely; Natella Y Rakhmanina
Journal:  Clin Pharmacokinet       Date:  2011-03       Impact factor: 6.447

Review 3.  Antiretroviral pharmacokinetics in the paediatric population: a review.

Authors:  Jennifer R King; David W Kimberlin; Grace M Aldrovandi; Edward P Acosta
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Pharmacokinetics of antiretroviral therapy in HIV-1-infected children.

Authors:  Pieter L A Fraaij; Jeroen J A van Kampen; David M Burger; Ronald de Groot
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  Indinavir/low-dose ritonavir containing HAART in HIV-1 infected children has potent antiretroviral activity, but is associated with side effects and frequent discontinuation of treatment.

Authors:  P L A Fraaij; G Verweel; A M C van Rossum; N G Hartwig; D M Burger; R de Groot
Journal:  Infection       Date:  2007-06       Impact factor: 3.553
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.